Neurotech International Ltd - NTI share price
About
Neurotech International Limited, an Australian biopharmaceutical company, focuses on developing and commercializing neurological solutions, primarily targeting pediatric neurological disorders. The company's endeavors include clinical studies on NTI/Dolce cannabis strains, examining their neuro-protective and anti-inflammatory properties. Neurotech's flagship product, Mente Autism, is a portable EEG medical device in the form of a headband. Utilizing closed-loop neurofeedback, it aims to help relax the minds of children with autism spectrum disorder (ASD). The company's commitment to innovation is evident in its completed Phase I/II clinical trial for NTI164, addressing ASD treatment. Neurotech is dedicated to advancing therapies that enhance the lives of those affected by neurological disorders.
Company Profile
Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.
Price Summary
Price Chart
Get Your FREE Report
Discover the Top ASX Stocks to Invest In 2026!
Expert Analysis of Top-Performing ASX Stocks
Market Insights and In-Depth Research
Buy, Sell, And Hold Recommendations
Almost There!
Enter your details to download the report
Success!
Preparing your download...
Latest Reports from Veye
Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026
Latest Article
